RecruitingNot ApplicableNCT07404254

Effects of Variations in Caffeinated Beverages on Well-being

A Randomized, Double-Blind, Parallel Trial to Assess Subjective and Physiological Responses to Consumption of Caffeinated Beverages in Healthy Adults With a Caffeine Routine


Sponsor

GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.

Enrollment

75 participants

Start Date

Jan 5, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverage variations in generally healthy adults.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Caffeinated beverage, Caffeinated, low sugar beverage, and others for people with beverage intake, caffeine, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCaffeinated, low sugar beverage

Participants will consume a caffeinated beverage with variations in sweetener and caffeine content.

OTHERCaffeinated beverage

Participants will consume a caffeinated beverage with variations in sweetener and caffeine content.

OTHERControl beverage

Participants will consume a caffeinated beverage with the control level of sweetener and caffeine content.


Locations(1)

Alethios, Inc.

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07404254


Related Trials